Literature DB >> 12832612

Optimization of protease-inhibitor interactions by randomizing adventitious contacts.

Tomoko Komiyama1, Bryan VanderLugt, Martin Fugère, Robert Day, Randal J Kaufman, Robert S Fuller.   

Abstract

Polypeptide protease inhibitors are often found to inhibit targets with which they did not coevolve, as in the case of high-affinity inhibition of bacterial subtilisin by the leech inhibitor eglin c. Two kinds of contacts exist in such complexes: (i) reactive site loop-active site contacts and (ii) interactions outside of these that form the broader enzyme-inhibitor interface. We hypothesized that the second class of "adventitious" contacts could be optimized to generate significant increases in affinity for a target enzyme or discrimination of an inhibitor for closely related target proteases. We began with a modified eglin c, Arg-42-Arg-45-eglin, in which the reactive site loop had been optimized for subtilisin-related processing proteases of the Kex2/furin family. We randomized 10 potential adventitious contact residues and screened for inhibition of soluble human furin. Substitutions at one of these sites, Y49, were also screened against yeast Kex2 and human PC7. These screens identified not only variants that exhibited increased affinity (up to 20-fold), but also species that exhibited enhanced selectivity, that is, increased discrimination between the target enzymes (up to 41-fold for furin versus PC7 and 20-fold for PC7 versus furin). One variant, Asp-49-Arg-42-Arg-45-eglin, exhibited a Ki of 310 pM for furin and blocked furin-dependent processing of von Willebrand factor in COS-1 cells when added to the culture medium of the cells. The exploitation of adventitious contact sites may provide a versatile technique for developing potent, selective inhibitors for newly discovered proteases and could in principle be applied to optimize numerous protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832612      PMCID: PMC166207          DOI: 10.1073/pnas.1032865100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  26 in total

1.  Importance of the P4' residue in human granzyme B inhibitors and substrates revealed by scanning mutagenesis of the proteinase inhibitor 9 reactive center loop.

Authors:  J Sun; J C Whisstock; P Harriott; B Walker; A Novak; P E Thompson; A I Smith; P I Bird
Journal:  J Biol Chem       Date:  2001-02-01       Impact factor: 5.157

Review 2.  Structural basis of the endoproteinase-protein inhibitor interaction.

Authors:  W Bode; R Huber
Journal:  Biochim Biophys Acta       Date:  2000-03-07

3.  Molecular sieve mechanism of selective release of cytoplasmic proteins by osmotically shocked Escherichia coli.

Authors:  N Vázquez-Laslop; H Lee; R Hu; A A Neyfakh
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

4.  Preferred sequence requirements for cleavage of pro-von Willebrand factor by propeptide-processing enzymes.

Authors:  A Rehemtulla; R J Kaufman
Journal:  Blood       Date:  1992-05-01       Impact factor: 22.113

5.  Engineered eglin c variants inhibit yeast and human proprotein processing proteases, Kex2 and furin.

Authors:  T Komiyama; R S Fuller
Journal:  Biochemistry       Date:  2000-12-12       Impact factor: 3.162

6.  Inhibition of the membrane fusion machinery prevents exit from the TGN and proteolytic processing by furin.

Authors:  A M Band; J Määttä; L Kääriäinen; E Kuismanen
Journal:  FEBS Lett       Date:  2001-09-07       Impact factor: 4.124

7.  Analysis of mutations in alleles of the fur gene from an endoprotease-deficient Chinese hamster ovary cell strain.

Authors:  M J Spence; J F Sucic; B T Foley; T J Moehring
Journal:  Somat Cell Mol Genet       Date:  1995-01

8.  A mutation of furin causes the lack of precursor-processing activity in human colon carcinoma LoVo cells.

Authors:  S Takahashi; K Kasai; K Hatsuzawa; N Kitamura; Y Misumi; Y Ikehara; K Murakami; K Nakayama
Journal:  Biochem Biophys Res Commun       Date:  1993-09-15       Impact factor: 3.575

9.  Failure of ventral closure and axial rotation in embryos lacking the proprotein convertase Furin.

Authors:  A J Roebroek; L Umans; I G Pauli; E J Robertson; F van Leuven; W J Van de Ven; D B Constam
Journal:  Development       Date:  1998-12       Impact factor: 6.868

10.  alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent.

Authors:  F Jean; K Stella; L Thomas; G Liu; Y Xiang; A J Reason; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 12.779

View more
  17 in total

1.  Inhibition of prohormone convertases PC1/3 and PC2 by 2,5-dideoxystreptamine derivatives.

Authors:  Mirella Vivoli; Thomas R Caulfield; Karina Martínez-Mayorga; Alan T Johnson; Guan-Sheng Jiao; Iris Lindberg
Journal:  Mol Pharmacol       Date:  2011-12-14       Impact factor: 4.436

2.  Screened nonbonded interactions in native proteins manipulate optimal paths for robust residue communication.

Authors:  Ali Rana Atilgan; Deniz Turgut; Canan Atilgan
Journal:  Biophys J       Date:  2007-02-09       Impact factor: 4.033

3.  Structure of an Fab-protease complex reveals a highly specific non-canonical mechanism of inhibition.

Authors:  Christopher J Farady; Pascal F Egea; Eric L Schneider; Molly R Darragh; Charles S Craik
Journal:  J Mol Biol       Date:  2008-05-11       Impact factor: 5.469

Review 4.  Mechanisms of macromolecular protease inhibitors.

Authors:  Christopher J Farady; Charles S Craik
Journal:  Chembiochem       Date:  2010-11-22       Impact factor: 3.164

5.  Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamine.

Authors:  Guan-Sheng Jiao; Lynne Cregar; Jinzhi Wang; Sherri Z Millis; Cho Tang; Sean O'Malley; Alan T Johnson; Sina Sareth; Jason Larson; Gary Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-18       Impact factor: 11.205

6.  Stability of mutant serpin/furin complexes: dependence on pH and regulation at the deacylation step.

Authors:  Erick K Dufour; Antoine Désilets; Jean-Michel Longpré; Richard Leduc
Journal:  Protein Sci       Date:  2005-02       Impact factor: 6.725

7.  A Kunitz trypsin inhibitor from chickpea (Cicer arietinum L.) that exerts anti-metabolic effect on podborer (Helicoverpa armigera) larvae.

Authors:  Ajay Srinivasan; Ashok P Giri; Abhay M Harsulkar; John A Gatehouse; Vidya S Gupta
Journal:  Plant Mol Biol       Date:  2005-02       Impact factor: 4.076

8.  Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis.

Authors:  Daniel E Bassi; Jirong Zhang; Jonathan Cenna; Samuel Litwin; Edna Cukierman; Andres J P Klein-Szanto
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

9.  Selective abolition of pancreatic RNase binding to its inhibitor protein.

Authors:  Kapil Kumar; Michael Brady; Robert Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-17       Impact factor: 11.205

10.  Opposite roles of furin and PC5A in N-cadherin processing.

Authors:  Deborah Maret; Mohamad Seyed Sadr; Emad Seyed Sadr; David R Colman; Rolando F Del Maestro; Nabil G Seidah
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.